In highly regulated industries, employee learning is no longer simply an HR function. It is increasingly part of the operating infrastructure that determines how effectively organizations manage compliance, technology adoption and workforce capability. At AstraZeneca, Kari Borroel is bringing those priorities together through a global approach to operations quality learning and development.

For organizations operating under stringent regulatory requirements, training has consequences far beyond course completion.

In life sciences, employees need to understand evolving processes, quality requirements and regulatory expectations while also adapting to new technologies and changing business priorities. That creates a difficult challenge for HR and operations leaders: how do organizations build workforce capability without treating learning as a disconnected administrative function?

Kari Borroel, MBA, Head of Operations Quality Learning and Development at AstraZeneca, has built her career around that intersection of learning, transformation and operational performance.

Her current responsibilities span the global strategy, design and execution of regulated GxP learning programs across operations and Quality functions. GxP refers broadly to the “good practice” frameworks governing regulated activities in the life sciences, where employee capability and documented processes can directly affect quality and compliance.

Borroel’s role therefore sits at the intersection of HR technology, learning and development, compliance and enterprise operations.

Rather than viewing learning as an isolated employee benefit, her approach positions capability building as part of the infrastructure required to operate effectively in a regulated environment. That includes enterprise learning governance, compliance training systems and broader initiatives intended to help employees perform consistently as business and regulatory requirements change.

The distinction is increasingly important as life sciences companies undergo digital transformation.

Pharmaceutical and healthcare organizations are adopting cloud platforms, automation, artificial intelligence and increasingly sophisticated data systems across research, manufacturing, quality and commercial operations. Those technologies can improve productivity, but their value depends on whether employees understand how to use them within established processes and regulatory boundaries.

That makes the learning function an important component of technology adoption.

Borroel brings experience from both sides of that equation. Before joining AstraZeneca, she held senior positions at Alexion Pharmaceuticals, where her responsibilities included quality learning, documentation and digital quality management systems. Earlier roles with organizations including Biogen, Aasonn and First Data Corporation expanded her experience across consulting, enterprise systems and organizational transformation.

Across those positions, a consistent theme has emerged: technology transformation requires corresponding changes in people, processes and organizational behavior.

That principle is now becoming more visible across enterprise HR technology.

Traditional learning management systems were largely designed to distribute courses, track completion and support compliance reporting. Modern learning experience platforms (LXPs) and talent-management systems increasingly seek to connect learning with skills, career development, workforce planning and business outcomes.

Artificial intelligence is accelerating that evolution.

AI can help organizations identify skills gaps, recommend learning content and personalize development paths. In regulated environments, however, automation must operate alongside governance and human oversight. Training recommendations cannot be separated from requirements around accuracy, documentation, privacy and compliance.

This creates a more complex role for learning leaders.

They increasingly need to understand not only instructional design, but also enterprise technology, data, change management and operational strategy.

Borroel’s career reflects that broader skill set. Her work encompasses global transformation, organizational development, performance improvement, change management and enterprise systems integration, while also requiring leadership across distributed teams.

Her leadership philosophy places considerable emphasis on continuous learning.

That extends beyond formal training. Borroel advocates remaining alert to emerging opportunities, industry developments and unexpected career paths. Her own professional trajectory—from consulting and enterprise technology environments to life sciences quality and learning leadership—illustrates how career development can evolve through exposure to new disciplines.

She also emphasizes mentorship and collaboration.

Large-scale organizational transformation is rarely accomplished by one function operating independently. HR, IT, operations, quality and business leaders increasingly have to coordinate when implementing new technology or redesigning work. Learning teams can serve as a bridge between those groups by translating strategic changes into the capabilities employees need.

That collaborative model is particularly relevant as life sciences organizations navigate cost pressures, political uncertainty, changing markets and regulatory complexity.

For pharmaceutical companies, transformation is no longer a one-time project. New technologies and operating models continually create new capability requirements. A learning strategy that cannot adapt quickly risks becoming disconnected from the business it is intended to support.

Borroel’s approach treats that constant change as an opportunity rather than simply a disruption.

Her academic background includes an MBA from Boston University Questrom School of Business, along with additional leadership training through the Project Management Institute and Harvard University. She is also involved with The Boston Club, contributing to initiatives supporting women’s leadership and organizational impact.

Her perspective on leadership is grounded in honesty, integrity, transparency, inclusion and accountability.

Those qualities may sound separate from technology strategy, but they become increasingly important as AI and automation influence workplace decisions. Employees need to trust the systems through which organizations deliver training, assess capabilities and manage change. Leaders, meanwhile, need reliable mechanisms for translating organizational priorities into workforce action.

For HR technology teams, Borroel’s work illustrates how the learning function is expanding.

The modern learning leader is increasingly expected to connect employee development with compliance, operational performance, technology adoption and business transformation. In highly regulated sectors, that connection can be especially consequential.

The broader lesson is that workforce transformation does not end when a new enterprise system goes live.

Employees need the skills to use it. Managers need to understand new workflows. Compliance teams need confidence in the controls. And organizations need mechanisms for continuously adapting as technology and regulation evolve.

That places continuous learning and capability development closer to the center of enterprise transformation than they have traditionally been.

Market Landscape

The HRTech and corporate learning technology market is moving toward greater integration between learning, skills intelligence, workforce analytics and enterprise transformation.

Platforms from Workday, SAP SuccessFactors, Oracle and Cornerstone increasingly connect learning and talent data with broader employee lifecycle systems. Meanwhile, AI is creating new possibilities for personalized learning recommendations, skills inference and automated workforce development.

For regulated industries such as pharmaceuticals, biotechnology and healthcare, adoption comes with additional requirements. Learning systems must support auditability, governance and compliance alongside usability and personalization.

The competitive advantage may therefore shift from simply having a large training catalog to building a connected skills and capability infrastructure that can respond to business change.

Borroel’s career reflects that transition: learning and development increasingly operates as a strategic capability rather than a back-office HR process.

Top Insights

• AstraZeneca’s Kari Borroel connects regulated learning, enterprise technology and operational performance, illustrating how HR functions are becoming strategic transformation partners.
• Her GxP learning responsibilities highlight the importance of workforce capability in highly regulated life sciences environments where compliance and operational execution intersect.
• AI and learning technologies are shifting corporate training from course administration toward skills intelligence, personalized development and continuous workforce capability building.
• Borroel’s career across AstraZeneca, Alexion Pharmaceuticals, Biogen and enterprise technology consulting demonstrates the growing convergence of learning, systems integration and transformation.
• Her leadership philosophy emphasizes mentorship, transparency, inclusion and continuous learning as organizations navigate technology, regulatory and market-driven change.

Join thousands of HR leaders who rely on HRTechEdge for the latest in workforce technology, AI-driven HR solutions, and strategic insights